Patient Power: Does the Transplant Treatment Approach Still Have Value for Myeloma Patients?
Do myeloma patients still need transplants in the age of so many newer treatment strategies? A panel of myeloma experts, including Carol Ann Huff MD, Suzanne Lentzsch, MD, PhD, and Sagar Lonial MD, FACP, addressed this topic during a recent interview.
Dr. Huff affirmed that for “the vast majority of people, the data supports that transplant is better than no transplant.”
There is still not enough information because long-term follow up isn’t yet available, but she suspects that with time there will be greater survival rates among those patients who have chosen the transplant treatment. The panel of myeloma experts agree that transplant is the best option for treatment care until further research and analyses say otherwise.